‹‹ Go Back

Kao-Tai Tsai

Celgene Corporation



‹‹ Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

←Back IconGems-Print

704 – Topics in Late-Phase Clinical Trial Research: Randomization, Group Sequential Designs, and Comparing Adverse Event Profiles

Joint Modeling of Efficacy and Laboratory Data in Clinical Trials

Sponsor: Biopharmaceutical Section
Keywords: Laboratory test data, joint model, clinical trial

Kao-Tai Tsai

Celgene Corporation

Joint modeling of time-to-event data such as survival or time to disease progression incorporating with the longitudinal data has been an active research topic. Software programs are also available in the public domain to perform this kind of data analysis. However, most of the programs are limited to one longitudinal data series and to extend this to multiple longitudinal series is remaining as a challenge. In this research, we estimate the treatment effects on disease progression using joint modeling with multiple data series of laboratory tests. We also estimate the variations of estimates via bootstrap. We compare the results from the existing software programs with respect to their consistency. Data from a recent clinical trial is used to illustrate the proposed approach.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2016 CadmiumCD